Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery
Haonan Li,Jie Cui,Tianyi Zhang,Fengli Lin,Guimin Zhang,Zhong Feng
DOI: https://doi.org/10.2147/ijn.s487313
IF: 7.033
2024-12-04
International Journal of Nanomedicine
Abstract:Haonan Li, 1 Jie Cui, 1 Tianyi Zhang, 2 Fengli Lin, 2 Guimin Zhang, 1, 3 Zhong Feng 1– 3 1 College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People's Republic of China; 2 Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People's Republic of China; 3 Lunan Pharmaceutical Group Co., Ltd., Linyi, Shandong, 276000, People's Republic of China Correspondence: Zhong Feng; Guimin Zhang, College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People's Republic of China, Email ; As a type of transdermal drug delivery system (TDDS), Microneedles (MNs) have garnered significant attention from researchers due to their ability to penetrate the stratum corneum (SC) of the skin, enhance drug permeability and bioavailability, avoid first-pass metabolism, and cause minimal damage to the skin. This makes them particularly suitable for localized transdermal drug delivery. Dissolvable microneedles (DMNs) can encapsulate sensitive particles, provide high drug-loading capacity, and possess biodegradability and biocompatibility, attracting extensive research interest. Chitosan (CS) has been selected as the matrix for manufacturing DMNs due to its excellent properties, including not eliciting an immune response in vivo and having active functional groups such as hydroxyl and amino groups that allow for modifications to impart appropriate mechanical strength and functionality to DMNs for specific applications. This paper provides a comprehensive review of the research status of various chitosan-based microneedles (CSMNs), explores the mechanisms of their dissolution in vivo, and discusses their applications in promoting wound healing, delivering macromolecular drugs, vaccine delivery, and anti-tumor therapies. Keywords: transdermal drug delivery, microneedles, dissolvable microneedles, chitosan, chitosan-based microneedles Compared to traditional drug delivery methods, the transdermal drug delivery system (TDDS) offers advantages such as avoiding first-pass metabolism and providing prolonged, stable control of drug input rates. 1 TDDS can control drug delivery through the skin at a determined rate to achieve systemic circulation, maintaining the actual clinical concentration over a prolonged period. 2 TDDS includes various methods such as patches, 3 creams, 4 and subcutaneous injections. 5 However, subcutaneous injections can cause pain and discomfort, leading to low patient compliance. The skin serves as a barrier against external environmental stimuli. It comprises the stratum corneum (SC), epidermis, and dermis. 6 The unique structure of the SC limits the penetration of most drugs, posing significant challenges in designing topical formulation. 7,8 The presence of the SC adversely affects the drug penetration rate and drug utilization rate of patches and creams. Compounds that improve penetration are known as "skin enhancers" or "penetration enhancers", but some may disrupt the skin barrier, leading to cytotoxicity. 9,10 Researchers have already attempted various methods such as liposomes, 11 nanoparticles, 12 vesicles. 13 Iontophoresis 14 and sonophoresis 15 to overcome the permeation barrier of the stratum corneum (SC). 16 However, the poor efficiency of traditional transdermal drug delivery strategies, the high cost of expensive equipment, and the painful and invasive treatment process result in low patient compliance. Therefore, there is an urgent need to develop advanced transdermal drug delivery strategies. Microneedles (MNs), as a novel drug delivery system composed of an array of microneedles, have garnered significant attention due to their minimally invasive nature, ease of use, localized and controlled drug delivery, and excellent drug loading capabilities. 17 Based on the aforementioned advantages, microneedles (MNs) have gained significant attention in the treatment of various diseases, particularly chronic conditions such as diabetes. 18 MNs can be classified into solid microneedles, 19 coated microneedles, 20 dissolvable microneedles, 21 and hollow microneedles. 22 The classification is shown in Figure 1. Solid MNs are the earliest type of microneedles and are classified into silicon and metal microneedles based on the materials used. Solid microneedles are primarily utilized to create microchannels in the skin, through which therapeutic solutions can be applied. However, they tend to cause significant skin damage, and the wounds created can easily become infected during the healing pr -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology